invention-intake

Invention disclosure triage screens for novelty signals, obviousness flags, US §101 eligibility risk, and disclosure or bar-date timing to determine whether to commission prior-art search routing and escalate to patent counsel. It produces a non-lawyer first-pass recommendation memo.

Deciding between a trade secret vs patent requires evaluating the detectability of the invention during intake screening. If the invention is difficult to detect externally, trade-secret routing is recommended; otherwise, pursuing a patent may be more appropriate to protect the strategic value.

Checking US §101 eligibility risk involves a structured screening pass during invention intake to identify potential issues with subject matter eligibility. The triage process generates a specific check, warning, or critical verdict with short reasoning for this eligibility screen.

If an invention disclosure is missing key facts for prior-art search routing, the triage process recommends an INVESTIGATE decision and outlines inventor follow-up steps to request the missing information before proceeding with a legal screening memo.

No, an invention intake screening tool cannot decide patentability. Guardrails strictly enforce that the triage process does not make patentability conclusions or perform prior-art searching, but instead recommends whether to commission a search and route to patent counsel.

You need to worry about public disclosure bar dates during invention intake when the invention has been publicly disclosed or used. The triage process includes a specific screening pass to assess public disclosure and bar-date timing risk to prevent loss of patent rights.